• Users Online: 41
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2020  |  Volume : 18  |  Issue : 4  |  Page : 380-384

Association between growth differentiation factor-15 and cardiovascular risk in patients with type 2 diabetes mellitus


Department and Institution Clinical Pathology, Faculty of Medicine, Al-Azhar University, Assiut, Egypt

Correspondence Address:
Fatma E.Z.M Abu-Bakr
Department and Institution Clinical Pathology, Faculty of Medicine, Al-Azhar University, 10 Street, Salama Hegazy, Assiut, 71511
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/AZMJ.AZMJ_101_20

Rights and Permissions

Background and aim As most diabetic patients have high risk of cardiovascular hazards, the aim was to assess an indicator biomarker that can help us to estimate these hazards in patients with type 2 diabetes (T2D). Patients and methods A total of 80 participants were examined for T2D and divided into two groups: T2D group and control group. To estimate the 10-year risk of atherosclerotic cardiovascular disease, we utilized the Framingham risk score (FRS), the New Pooled Cohort Equation score, Tch/high-density lipoprotein (HDL) ratio, HDL/low-density lipoprotein (LDL) ratio, and serum growth differentiation factor-15 (GDF15). Results The T2D group had higher levels of systolic blood pressure and diastolic blood pressure and lower levels of weight and BMI than control. The T2D group had higher levels of random blood glucose (RBG), glycosylated hemoglobin, and urea. Both the total cholesterol/HDL and LDL/HDL were high significantly in the T2D, whereas FRS was high in the T2D group than control group. The level of serum GDF15 was higher in the T2D group (P=0.000). We found a positive correlation between level of serum GDF15 and BMI (r=0.336, P=0.017), systolic blood pressure (r=0.622, P=0.000), diastolic blood pressure (r=0.572, P=0.000), RBG (r=0.298, P=0.035), and FRS (r=0.415, P=0.003). Conclusion GDF15 can be used as an indicator for measuring cardiovascular hazards in patients with T2D.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed557    
    Printed34    
    Emailed0    
    PDF Downloaded51    
    Comments [Add]    

Recommend this journal